Sharescart Research Club logo

Care Ratings Overview

CARE Ratings Ltd, a credit rating organization, presents diverse rating and grading services in India, Mauritius, and Nepal. The agency presents rating offerings for debt gadgets, inclusive of bonds, debentures, hybrid instruments, preference shares, fixed deposits, commercial papers and short-term debt applications, and certificate of deposits; and financial institution mortgage; financial region rating offerings, which cover banks, non-banking finance agencies, housing finance corporations, financial establishments, and so on.; structured fin...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Care Ratings Key Financials

Market Cap ₹5088 Cr.

Stock P/E 36.3

P/B 5.7

Current Price ₹1693.4

Book Value ₹ 298.9

Face Value 10

52W High ₹1964.8

Dividend Yield 1.06%

52W Low ₹ 1150

Care Ratings Share Price

₹ | |

Volume
Price

Care Ratings Quarterly Price

Show Value Show %

Care Ratings Peer Comparison

Care Ratings Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 96 79 90 79 117 96 110 94 136 112
Other Income 11 14 10 12 12 12 15 14 13 13
Total Income 108 92 100 91 129 108 125 108 149 125
Total Expenditure 55 55 61 57 62 66 62 66 68 72
Operating Profit 53 37 39 34 68 42 63 41 81 53
Interest 0 0 0 0 0 1 1 1 1 1
Depreciation 3 3 3 3 3 3 3 3 3 4
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 50 34 36 30 64 39 59 37 77 49
Provision for Tax 14 10 12 9 17 10 16 11 20 12
Profit After Tax 36 24 25 21 47 28 43 26 57 37
Adjustments -1 -0 -0 -1 -1 -1 -1 -1 -1 -1
Profit After Adjustments 35 23 24 21 46 28 43 26 57 36
Adjusted Earnings Per Share 11.8 7.9 8.1 6.9 15.4 9.3 14.2 8.6 18.9 12

Care Ratings Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 261 279 287 333 319 244 248 248 279 332 402 452
Other Income 44 9 34 25 30 31 31 27 38 47 51 55
Total Income 304 288 321 358 349 275 280 275 317 378 453 507
Total Expenditure 101 105 105 122 144 162 153 168 180 220 247 268
Operating Profit 203 183 216 236 205 113 127 107 137 159 206 238
Interest 1 0 0 0 0 1 1 0 1 2 2 4
Depreciation 5 4 3 3 3 8 8 8 11 10 12 13
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 197 178 212 233 202 104 119 99 126 147 192 222
Provision for Tax 59 59 65 71 64 21 28 22 40 44 52 59
Profit After Tax 138 120 148 162 138 83 91 77 85 103 140 163
Adjustments 0 0 0 0 -1 -1 -1 -2 -2 -2 -3 -4
Profit After Adjustments 138 120 148 162 137 82 90 75 84 101 137 162
Adjusted Earnings Per Share 47.5 40.7 50.1 55.1 46.7 28 30.4 25.3 28.1 33.7 45.9 53.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 21% 17% 11% 4%
Operating Profit CAGR 30% 24% 13% 0%
PAT CAGR 36% 22% 11% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 32% 36% 26% 6%
ROE Average 19% 16% 15% 22%
ROCE Average 26% 22% 21% 31%

Care Ratings Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 359 409 520 597 550 533 589 647 672 717 806
Minority's Interest 0 0 0 2 2 3 4 5 7 7 9
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 312 371 15 9 13 22 25 21 33 38 44
Total Current Liabilities 78 86 475 551 611 541 557 584 58 79 98
Total Liabilities 749 866 1010 1159 1177 1099 1175 1257 770 842 958
Fixed Assets 65 64 61 60 83 93 85 96 107 109 119
Other Non-Current Assets 501 593 83 257 252 229 40 65 61 58 146
Total Current Assets 184 209 866 842 842 777 1050 1096 602 675 692
Total Assets 749 866 1010 1159 1177 1099 1175 1257 770 842 958

Care Ratings Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 25 13 12 13 24 20 7 12 18 49 38
Cash Flow from Operating Activities 107 106 119 134 109 67 86 68 82 91 123
Cash Flow from Investing Activities 157 -41 -22 -25 83 27 -38 -27 13 -39 -58
Cash Flow from Financing Activities -276 -66 -96 -99 -195 -107 -43 -35 -63 -63 -54
Net Cash Inflow / Outflow -12 -1 1 11 -4 -13 5 6 32 -11 11
Closing Cash & Cash Equivalent 13 12 13 24 20 7 12 18 49 38 49

Care Ratings Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 47.53 40.68 50.13 55.13 46.66 27.96 30.38 25.33 28.12 33.67 45.85
CEPS(Rs) 49.28 42.1 51.27 56.17 47.99 30.97 33.52 28.51 32.32 37.87 50.69
DPS(Rs) 79 28 28 55 30 19.5 17 17 25 18 18
Book NAV/Share(Rs) 121.46 138.53 176.5 199.65 179.42 173.02 191.49 215.75 224.16 238.52 267.56
Core EBITDA Margin(%) 61.24 62.24 63.39 63.35 54.76 33.38 38.55 32.15 35.61 33.81 38.61
EBIT Margin(%) 76.06 63.86 73.93 70.06 63.24 43.1 48 40.02 45.43 44.72 48.31
Pre Tax Margin(%) 75.56 63.86 73.93 70.06 63.24 42.72 47.76 39.83 45.07 44.21 47.79
PAT Margin (%) 52.9 42.81 51.36 48.8 43.29 34.26 36.61 31.03 30.63 30.92 34.8
Cash Profit Margin (%) 54.85 44.31 52.54 49.74 44.33 37.45 39.75 34.14 34.4 34.08 37.71
ROA(%) 17.52 14.82 15.74 14.97 11.82 7.34 8 6.32 8.43 12.73 15.56
ROE(%) 32.96 31.49 31.85 29.3 24.73 16.08 16.94 12.76 13.09 14.89 18.51
ROCE(%) 46.94 46.48 45.76 41.74 35.18 19.39 21.26 16.03 19.21 21.35 25.52
Receivable days 21.39 25.71 31.06 35.4 49.49 66.03 45.73 28 24.22 23.59 24.75
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 31.07 22.92 33.06 21.96 21.18 11.79 13.53 20.21 22.86 33.18 24.01
Price/Book(x) 12.16 6.73 9.39 6.06 5.51 1.9 2.15 2.37 2.87 4.68 4.11
Dividend Yield(%) 5.35 3 1.69 4.54 3.04 5.92 4.13 3.32 3.89 1.61 1.64
EV/Net Sales(x) 16.38 9.77 16.93 10.63 9.03 3.51 3.71 5.8 6.64 9.88 7.95
EV/Core EBITDA(x) 21 14.94 22.54 14.98 14.05 7.59 7.25 13.45 13.5 20.63 15.52
Net Sales Growth(%) 10.6 7.22 2.89 15.74 -4.12 -23.62 1.97 -0.33 12.66 18.89 21.3
EBIT Growth(%) 9.74 -9.98 19.11 9.69 -13.45 -47.94 13.56 -16.91 27.91 17.04 31.03
PAT Growth(%) 6.3 -13.22 23.42 9.97 -14.95 -39.54 8.97 -15.54 11.23 20.02 36.5
EPS Growth(%) 6.5 -14.41 23.24 9.97 -15.36 -40.08 8.67 -16.62 11.01 19.74 36.16
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.34 2.43 1.82 1.53 1.38 1.44 1.88 1.88 10.41 8.57 7.08
Quick Ratio(x) 2.34 2.43 1.82 1.53 1.38 1.44 1.88 1.88 10.41 8.57 7.08
Interest Cover(x) 152.53 0 0 0 0 113.23 193.14 213.66 126.55 86.65 92.2
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Care Ratings Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 0 0 0 0 0 0 0 0 0 0
FII 21.67 22.91 23.37 24.8 24.75 23.74 24.62 23.61 23 23.25
DII 26.32 26.89 26.15 25.28 27.51 29.38 29.76 31.6 31.3 31.39
Public 52.01 50.2 50.48 49.93 47.74 46.88 45.62 44.79 45.7 45.37
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Care Ratings News

Care Ratings Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 0%.
  • Stock is trading at 5.7 times its book value.
whatsapp